Last reviewed · How we verify
NCT05599425
Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
NA trial testing Enhanced Healthy Living Education in Alzheimer Disease in 40 participants. Currently enrolling.
30 December 2024
Quick facts
| Lead sponsor | Rhode Island Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 1 March 2024 |
| Primary completion | 30 December 2024 |
| Estimated completion | 1 February 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Enhanced Healthy Living Education
- Basic Healthy Living Education
Conditions studied
- Alzheimer Disease — all drugs for Alzheimer Disease →
Sponsor
Rhode Island Hospital
Who can join
Adults 45 to 69, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Modifying health behaviors like physical activity level, diet, stress, and mental activity level can lower risk for Alzheimer's disease, but many middle-aged and older adults find it difficult to sustain health behavior changes over the long term. This project will develop a new intervention that educates people about Alzheimer's disease risk factors and helps them understand how their personal health beliefs may prevent them from making long-lasting lifestyle changes. The goal is to help people sustain health behavior changes to prevent or delay the onset of Alzheimer's disease and related dementias.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intervention Development for Tailored Education for Aging and Cognitive Health (TEACH) for Dementia Prevention in Midlife Adults: Protocol for a Randomized Controlled Trial.
Korthauer LE, Rosen RK, Tremont G, Davis JD. · · 2024 · cited 3× · PMID 39412840 · DOI 10.2196/60395
Verify or expand the search:
- PubMed search for NCT05599425
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alzheimer Disease
Currently open trials in the same condition.
- NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
- NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
- NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
- NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
- NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting
Other Rhode Island Hospital trials
Trials by the same sponsor.
- NCT06747221 — Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya · NA · not yet recruiting
- NCT07211087 — Improving the Treatment of Depression Among Youth With HIV · NA · not yet recruiting
- NCT06754527 — Options for Navigating Talking About Risk and Adolescent Choices · NA · not yet recruiting
- NCT07144631 — Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome · NA · recruiting
- NCT06942455 — A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05599425 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rhode Island Hospital
- Last refreshed: 25 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05599425.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing